Jeremy N. Bradbeer

Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

A M Badger, Jeremy N. Bradbeer, Bartholomew J. Votta et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 499 citations

Medicine, Immunology, Pharmacology +17

Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo

Bartholomew J. Votta, Mark A. Levy, Alison M. Badger et al. · Journal of Bone and Mineral Research · 1997 · 185 citations

Life Sciences, Biochemistry, Molecular Biology +16

A selective inhibitor of the osteoclastic V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats

L. Visentin, Robert A. Dodds, Maurizio Valente et al. · Journal of Clinical Investigation · 2000 · 130 citations · Full text

Medicine, Endocrinology, Pharmacology +15

hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses

J. Reeve, Jeremy N. Bradbeer, M. Arlot et al. · Osteoporosis International · 1991 · 128 citations

Medicine, Endocrinology, Pharmacotherapy +17

1-Substituted 4-Aryl-5-pyridinylimidazoles:  A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency

Jeffrey C. Boehm, Juanita M. Smietana, Margaret E. Sorenson et al. · Journal of Medicinal Chemistry · 1996 · 120 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17